PASADENA – The World Stem Cell Summit, now in its seventh year, will kick off three days of networking and seminars on Monday at the Pasadena Convention Center in hopes of spurring progress and investment in the emerging industry. The event promises more than 150 top international speakers and 50 hours of programming with industry leaders from science, pharmaceuticals, business, policy, ethics, law and more. Bernie Siegel, founder and co-chair of the Summit and executive director the Genetic Policy Institute (GPI), which produces the event, said this year’s focus on translational regenerative medicine is about asking “how do you take the phenomenal scientific research going on in labs and translate it into medical treatments? It’s a big job to do this, and more than just the science.”
Recent Posts
- The Download: what’s next for AI, and stem-cell therapies
- 10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs
- A pilot raced through the airport to surprise an old friend: the woman who saved his life
- 8 Trends to Watch in the Cell and Gene Therapy Market
- UNL researchers delving into which foods help slow aging of brain
- Australia’s Fast New 3D Bioprinter Can Mimic Human Tissues